Cargando…
Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bohn Stafleu van Loghum
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160039/ https://www.ncbi.nlm.nih.gov/pubmed/33970436 http://dx.doi.org/10.1007/s12471-021-01581-8 |
| _version_ | 1783700198894075904 |
|---|---|
| author | Walsh, R. Pinto, Y. M. |
| author_facet | Walsh, R. Pinto, Y. M. |
| author_sort | Walsh, R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8160039 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Bohn Stafleu van Loghum |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81600392021-06-17 Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants Walsh, R. Pinto, Y. M. Neth Heart J Editor’s Comment Bohn Stafleu van Loghum 2021-05-10 2021-06 /pmc/articles/PMC8160039/ /pubmed/33970436 http://dx.doi.org/10.1007/s12471-021-01581-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Editor’s Comment Walsh, R. Pinto, Y. M. Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants |
| title | Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants |
| title_full | Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants |
| title_fullStr | Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants |
| title_full_unstemmed | Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants |
| title_short | Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants |
| title_sort | improving risk prediction in hypertrophic cardiomyopathy: the key role of dutch founder variants |
| topic | Editor’s Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160039/ https://www.ncbi.nlm.nih.gov/pubmed/33970436 http://dx.doi.org/10.1007/s12471-021-01581-8 |
| work_keys_str_mv | AT walshr improvingriskpredictioninhypertrophiccardiomyopathythekeyroleofdutchfoundervariants AT pintoym improvingriskpredictioninhypertrophiccardiomyopathythekeyroleofdutchfoundervariants |